The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers

Anesthesiology

Volumn 88, Issue 5, 1998, Pages 1170-1182

  Schnider, Thomas W ^a,g   Minto, Charles F ^b   Gambus, Pedro L ^c   Andresen, Corina ^d   Goodale, David B ^e   Shafer, Steven L ^d,f   Youngs, Elizabeth J ^d,f  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF SYDNEY   (Australia)

^c HOSPITAL DE VILADECANS   (Spain)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ASTRAZENECA   (United Kingdom)

^f Veterans Affairs Palo Alto Health Care System

^g UNIVERSITY OF BERN   (Switzerland)

Author keywords

Age; EDTA; Linearity; Population

Indexed keywords

EDETIC ACID; PROPOFOL;

ADULT; AGE; AGED; ARTICLE; BODY HEIGHT; BOLUS INJECTION; CLINICAL TRIAL; COMPARTMENT MODEL; CONTINUOUS INFUSION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS ANESTHESIA; INTRAVENOUS DRUG ADMINISTRATION; LEAN BODY WEIGHT; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGING; ANESTHETICS, INTRAVENOUS; ANTIDOTES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; EDETIC ACID; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROPOFOL;

EID: 0031955972     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199805000-00006     Document Type: Article

References (33)

1. Gepts E, Camu F, Cockshott ID, Douglas EJ: Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 1987; 66:1256-63
2. Kirkpatrick T, Cockshott ID, Douglas EJ, Nimmo WS: Pharmacokinetics of propofol (diprivan) in elderly patients. Br J Anaesth 1988; 60:146-50
3. Gepts E, Jonckheer K, Maes V, Sonck W, Camu F: Disposition kinetics of propofol during alfentanil anaesthesia. Anaesthesia 1988; 43(Suppl):8-13
4. Tackley RM, Lewis GT, Prys-Roberts C, Boaden RW, Dixon J, Harvey JT: Computer controlled infusion of propofol. Br J Anaesth 1989; 62:46-53
5. Marsh B, White M, Morton N, Kenny GN: Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67:41-8
6. Vuyk J, Engbers FH, Burm AG, Vletter AA, Bovill JG: Performance of computer-controlled infusion of propofol: An evaluation of five pharmacokinetic parameter sets. Anesth Analg 1995; 81:1275-82
7. Bailey JM, Mora CT, Shafer SL: Pharmacokinetics of propofol in adult patients undergoing coronary revascularization: The Multicenter Study of Perioperative Ischemia Research Group. ANESTHESIOLOGY 1996; 84:1288-97
8. Sear JW, Diedericks J, Foex P: Continuous infusions of propofol administered to dogs: Effects on ICG and propofol disposition. Br J Anaesth 1994; 72:451-5
9. Coetzee JF, Glen JB, Wium CA, Boshoff L: Pharmacokinetic model selection for target controlled infusions of propofol: Assessment of three parameter sets. ANESTHESIOLOGY 1995; 82:1328-45
10. Dyck JB, Shafer SL: Effects of age on propofol pharmacokinetics. Semin Anesth 1992; 11:2-4
11. Bennett SN, McNeil MM, Bland LA, Arduino MJ, Villarino ME, Perrotta DM, Burwen DR, Welbel SF, Pegues DA, Stroud L: Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 1995; 333:147-54
12. Sosis MB, Braverman B, Villaflor E: Propofol, but not thiopental, supports the growth of Candida albicans. Anesth Analg 1995; 81:132 4
13. Sosis MB, Braverman B: Growth of Staphylococcus aureus in four intravenous anesthetics. Anesth Analg 1993; 77:766-8
14. Arduino MJ, Bland LA, McAllister SK, Aguero SM, Villarino ME, McNeil MM, Jarvis WR, Favero MS: Microbial growth and endotoxin production in the intravenous anesthetic propofol. Infect Control Hosp Epidemiol 1991; 12:535-9
15. Kempen PM: Contamination of syringes. Can J Anaesth 1989; 36:730-1
16. Mandema JW, Verotta D, Sheiner LB: Building population pharmacokinetic-pharmacodynamic models: I. Models for covariate effects. J Pharmacokinet Biopharm 1992; 20:511-28
17. Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJM, Gambus PL, Billard V, Hoke JF, Moore KHP, Hermann DJ, Muir KT, Mandema JW, Shafer SL: Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil: I. Model development. ANESTHESIOLOGY 1997; 86:10-23
18. Sheiner LB, Beal SL: Bayesian individualization of pharmacokinetics: Simple implementation and comparison with non-Bayesian methods. J Pharm Sci 1982; 71:1344-8
19. Beal SL, Sheiner LB: Estimating population kinetics. Crit Rev Biomed Eng 1982; 8:195-222
20. DuBois D, DuBois EF: Clinical calorimetry: X. A formula to estimate the approximate surface area if the height and weight be known. Arch Intern Med 1916; 17:863-71
21. Kataria BK, Ved SA, Nicodemus HF, Hoy GR, Lea D, Dubois MY, Mandema JW, Shafer SL: The pharmacokinetics of propofol in children using three different data analysis approaches. ANESTHESIOLOGY 1994; 80:104-22
22. Gustafsson LL, Ebling WF, Osaki E, Harapat S, Stanski DR, Shafer SL: Plasma concentration clamping in the rat using a computer-controlled infusion pump. Pharmacol Res 1992; 9:800-7
23. Schnider TW, Gaeta R, Brose W, Minto CF, Gregg KM, Shafer SL: Derivation and cross-validation of pharmacokinetic parameters for computer-controlled infusion of lidocaine in pain therapy. ANESTHESIOLOGY 1996; 84:1043-50
24. Lange H, Stephan H, Rieke H, Kellermann M, Sonntag H, Bircher J: Hepatic and extrahepatic disposition of propofol in patients undergoing coronary bypass surgery. Br J Anaesth 1990; 64:563-70
25. Henthorn TK, Avram MJ, Krejcie TC, Shanks CA, Asada A, Kaczynski DA: Minimal compartmental model of circulatory mixing of indocyanine green. Am J Physiol 1992; 262:H903-10
26. Krejcie TC, Henthorn TK, Niemann CU, Klein C, Gupta DK, Gentry WB, Shanks CA, Avram MJ: Recirculatory pharmacokinetic models of markers of blood, extracellular fluid and total body water administered concomitantly. J Pharmacol Exp Ther 1996; 278:1050-7
27. Pavlin DJ, Coda B, Shen DD, Tschanz J, Nguyen Q, Schaffer R, Donaldson G, Jacobson RC, Chapman CR: Effects of combining propofol and alfentanil on ventilation, analgesia, sedation, and emesis in human volunteers. ANESTHESIOLOGY 1996; 84:23-37
28. Zwetsch D, Bernath M, Decosterd L, Chassot PG, Ravussin P, Gardaz JP: First pass uptake of propofol in the human lung (abstract). ANESTHESIOLOGY 1996; 85:A329
29. Matot I, Neely CF, Katz RY, Marshall BE: Fentanyl and propofol uptake by the lung: Effect of time between injections. Acta Anaesthesiol Scand 1994; 38:711-5
30. Avram MJ, Krejcie TC, Henthom TK: The relationship of age to the pharmacokinetics of early drug distribution: The concurrent disposition of thiopental and indocyaninc green. ANESTHESIOLOGY 1990; 72:403-11
31. Stanski DR, Maitre PO: Population pharmacokinetics and pharmacodynamics of thiopental: The effect of age revisited. ANESTHESIOLOGY 1990; 72:412-22
32. Dudley HR, Ritchie ChB, Schilling A, Baker WH: Pathologic changes associated with the use of sodium ethylene diamine tetra-acetate in the treatment of hypercalcemia. N Engl J Med 1955; 252:331-7
33. Meltzer LE, Kitchell JR, Palmon JR: The long term use, side effects and toxicity of disodium ethylenediamine tetraacetic acid (EDTA). Am J Med Sci 1961; July: 51-7